The Institutional Biosafety Committee (IBC) is a federally-mandated research oversight committee charged with ensuring the safe acquisition, use, and disposal of all bio hazardous agents (including recombinant and synthetic nucleic acid molecules, infectious materials, and select agents) at DePaul University. It is the responsibility of the IBC to establish appropriate health and safety policies in accordance with federal regulations and guidelines that govern biological safety and to evaluate research and teaching activities at DePaul for biological safety considerations.
IBC Members
| Justin Maresh, PhD, Chair |
Department of Chemistry |
| David George, Vice Chair |
University of Chicago |
| Kathleen Abma |
Environmental Health and Safety |
| Jeremie Fant |
Chicago Botanic Garden |
Janine Kirin
|
Research Support Facility
|
| JingJing Kipp |
Department of Biological Sciences |
Megan Schrementi
|
Department of Biological Sciences
|
| Nicolette Zielinski-Mozny, DVM, PhD |
Northwestern University |
| Brian Henson (alternate Abma) |
Compliance and Risk Management |
|---|
| Jessica Bloom* |
Interim Director of Research Compliance - Academic Affairs |
| Daniela Stan Raicu* |
Associate Provost for Research |
*ex-officio advisors